Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dushyant V. Sahani, M.D.

Co-Author

This page shows the publications co-authored by Dushyant Sahani and Onofrio Catalano.
Connection Strength

2.918
  1. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology. 2010 Jan; 254(1):154-62.
    View in: PubMed
    Score: 0.426
  2. Vascular and biliary variants in the liver: implications for liver surgery. Radiographics. 2008 Mar-Apr; 28(2):359-78.
    View in: PubMed
    Score: 0.375
  3. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1871-1884.
    View in: PubMed
    Score: 0.211
  4. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR. Abdom Radiol (NY). 2017 04; 42(4):1141-1151.
    View in: PubMed
    Score: 0.176
  5. An overview of PET/MR, focused on clinical applications. Abdom Radiol (NY). 2017 02; 42(2):631-644.
    View in: PubMed
    Score: 0.174
  6. Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. Radiology. 2013 Dec; 269(3):857-69.
    View in: PubMed
    Score: 0.139
  7. Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy. J Hematol Oncol. 2013 Jul 10; 6:51.
    View in: PubMed
    Score: 0.136
  8. State-of-the-art PET/CT of the pancreas: current role and emerging indications. Radiographics. 2012 Jul-Aug; 32(4):1133-58; discussion 1158-60.
    View in: PubMed
    Score: 0.127
  9. Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time. Eur Radiol. 2011 Jun; 21(6):1293-300.
    View in: PubMed
    Score: 0.115
  10. New and evolving concepts in the imaging and management of urolithiasis: urologists' perspective. Radiographics. 2010 May; 30(3):603-23.
    View in: PubMed
    Score: 0.109
  11. Biliary infections: spectrum of imaging findings and management. Radiographics. 2009 Nov; 29(7):2059-80.
    View in: PubMed
    Score: 0.105
  12. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009 Oct; 29(6):1725-48.
    View in: PubMed
    Score: 0.105
  13. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr. 2009 May-Jun; 33(3):363-8.
    View in: PubMed
    Score: 0.102
  14. Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study. J Endourol. 2008 Oct; 22(10):2207-10.
    View in: PubMed
    Score: 0.098
  15. Cholangiocarcinoma: current and novel imaging techniques. Radiographics. 2008 Sep-Oct; 28(5):1263-87.
    View in: PubMed
    Score: 0.097
  16. Pixel distribution analysis: can it be used to distinguish clear cell carcinomas from angiomyolipomas with minimal fat? Radiology. 2008 Jun; 247(3):738-46.
    View in: PubMed
    Score: 0.095
  17. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol. 2008 Jan; 23(1):23-33.
    View in: PubMed
    Score: 0.093
  18. MR imaging of the gallbladder: a pictorial essay. Radiographics. 2008 Jan-Feb; 28(1):135-55; quiz 324.
    View in: PubMed
    Score: 0.093
  19. Lymphoepithelial cysts and cystic lymphangiomas: Under-recognized benign cystic lesions of the pancreas. World J Gastrointest Surg. 2014 Jul 27; 6(7):136-41.
    View in: PubMed
    Score: 0.037
  20. Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol. 2012 Sep; 85(1017):1211-21.
    View in: PubMed
    Score: 0.032
  21. Differential renal function estimation using computerized tomography based renal parenchymal volume measurement. J Urol. 2010 Jun; 183(6):2289-93.
    View in: PubMed
    Score: 0.027
  22. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol. 2009 Jun 20; 27(18):3027-35.
    View in: PubMed
    Score: 0.026
  23. Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): Insights from a multidisciplinary phase II study. J Clin Oncol. 2008 May 20; 26(15_suppl):4521.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.